3 studies found for:    14691125 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Phase II Trial of Pulsed Taxol With Concurrent Thoracic Radiotherapy, & Adjuvant Chemo in Stage III NSCLC
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Taxol (paclitaxel);   Procedure: Radiotherapy;   Drug: Carboplatin;   Drug: Gemcitabine
2 Unknown  Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: erlotinib;   Procedure: FDG-/FLT-PET
3 Completed
Has Results
A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II)
Conditions: NSCLC;   Solid Tumors
Interventions: Drug: YM155;   Drug: Carboplatin;   Drug: Paclitaxel

Indicates status has not been verified in more than two years